Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017		Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (1,622,122)		$ (1,232,683)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	807,610		48,000
Depreciation and amortization	43,370		41,966
Gain on remeasurement of warrant liability	(284,651)		0
Changes in operating assets and liabilities:
Inventory	(202,118)		171,491
Prepaid expenses	82,085		35,815
Lease deposit	1,425		0
Accounts payable and accounts payable – related parties	221,821		49,637
Accrued expenses and accrued expenses – related parties	172,156		97,866
Net cash used in operating activities	(780,424)		(787,908)
Cash flows from investing activities:
Cost of registering patents	(17,936)		(17,941)
Net cash used in investing activities	(17,936)		(17,941)
Cash flows from financing activities:
Principal payments on notes payable and notes payable – related parties	(35,054)		(56,534)
Issuance of common stock for cash	500,000		160,000
Net cash provided by financing activities	464,946		103,466
Effects of foreign currency exchange rates on cash	(4,355)		(5,507)
Net decrease in cash	(337,769)		(707,890)
Cash as of beginning of the period	398,290	[1]	745,078
Cash as of end of the period	60,521		37,188
Supplemental cash flow information:
Cash paid for interest	12,549		8,246
Settlement of accounts payable and accrued expenses with notes payable – related parties	0		1,617,881
Financing of insurance premiums	$ 38,141		$ 66,755

[1] The condensed consolidated balance sheet as of December 31, 2016 has been prepared using information from the audited consolidated balance sheet as of that date.